84
Participants
Start Date
February 28, 2025
Primary Completion Date
August 9, 2027
Study Completion Date
September 13, 2028
SAR442970
Pharmaceutical form: Solution Route of administration: Subcutaneous injection
Placebo
Pharmaceutical form: Solution Route of administration: Subcutaneous injection
RECRUITING
Investigational Site Number : 0320005, Buenos Aires
RECRUITING
Investigational Site Number : 0320004, Buenos Aires
RECRUITING
Investigational Site Number : 0360003, St Leonards
RECRUITING
Investigational Site Number : 0360001, Parkville
RECRUITING
Investigational Site Number : 0360002, Herston
RECRUITING
Investigational Site Number : 6820002, Riyadh
RECRUITING
Atlanta Diabetes Associates- Site Number : 8400006, Atlanta
RECRUITING
Centricity Research- Site Number : 8400012, Columbus
RECRUITING
Profound Research LLC at Millenium Affiliated Physicians - MHP TriAtria- Site Number : 8400015, Farmington Hills
RECRUITING
Investigational Site Number : 3760002, Ramat Gan
RECRUITING
Tekton Research LLC- Site Number : 8400017, McKinney
RECRUITING
Investigational Site Number : 3760001, Jerusalem
RECRUITING
Investigational Site Number : 1520004, Concepción
RECRUITING
Investigational Site Number : 3760003, Kfar Saba
RECRUITING
Investigational Site Number : 1520001, Santiago
RECRUITING
Investigational Site Number : 1520003, Santiago
RECRUITING
Investigational Site Number : 0320001, CABA
RECRUITING
Investigational Site Number : 0320002, Buenos Aires
RECRUITING
Investigational Site Number : 0320003, Salta
RECRUITING
Centro de Diabetes Curitiba - CDC- Site Number : 0760005, Curitiba
RECRUITING
CPCLIN - Centro de Pesquisas Clínicas- Site Number : 0760002, São Paulo
RECRUITING
Investigational Site Number : 1240006, Surrey
RECRUITING
Investigational Site Number : 1240001, Vancouver
Lead Sponsor
Sanofi
INDUSTRY